WEAVER GREGORY L — SEC insider filings

SEC reporting owner CIK 1251779. 21 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2021-05-18 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ATOSSA THERAPEUTICS, INC. (ATOS)Former EVP, CFO, & Director, Director71 leg · 50,000 sh · $48,5002 legs · 157,497 sh · $632,33313
Altimmune, Inc. (ALT)Chief Financial Officer114 legs · 35,000 sh · $117,395—16
ATAI Life Sciences N.V. (ATAI)Chief Financial Officer31 leg · 4,666 sh · $69,990—2

Insider filings — WEAVER GREGORY L

FiledFormIssuerReported transactionsSource
2026-11-134Altimmune, Inc. (ALT)Option exercise (M): 18,750 @ $0 · Tax withholding (F): 5,672 @ $1.93 · Option exercise (M): 18,750 (derivative) @ $0EDGAR
2026-11-134Altimmune, Inc. (ALT)Purchase (P): 10,000 @ $1.62EDGAR
2026-10-054Altimmune, Inc. (ALT)Option exercise (M): 14,475 @ $0 · Tax withholding (F): 4,379 @ $2.76 · Option exercise (M): 14,475 (derivative) @ $0EDGAR
2026-08-034Altimmune, Inc. (ALT)Grant/award (A): 1,753 @ $2.41EDGAR
2026-04-014Altimmune, Inc. (ALT)Purchase (P): 10,000 @ $3.15EDGAR
2026-03-094Altimmune, Inc. (ALT)Purchase (P): 5,000 @ $3.54EDGAR
2026-02-274Altimmune, Inc. (ALT)Grant/award (A): 259,000 (derivative) @ $0 · Grant/award (A): 111,000 (derivative) @ $0EDGAR
2025-11-124Altimmune, Inc. (ALT)Option exercise (M): 18,750 @ $0 · Tax withholding (F): 5,672 @ $4.28 · Option exercise (M): 18,750 (derivative) @ $0EDGAR
2025-10-034Altimmune, Inc. (ALT)Grant/award (A): 166,800 (derivative) @ $0 · Grant/award (A): 57,900 (derivative) @ $0EDGAR
2025-03-144Altimmune, Inc. (ALT)Purchase (P): 10,000 @ $5.20EDGAR
2024-11-124Altimmune, Inc. (ALT)Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2023-11-174ATOSSA THERAPEUTICS, INC. (ATOS)Sale (S): 50,000 @ $0.65EDGAR
2023-06-204ATOSSA THERAPEUTICS, INC. (ATOS)Purchase (P): 50,000 @ $0.97EDGAR
2023-06-054ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 2,600,000 (derivative) @ $0EDGAR
2023-05-054ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-05-164ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-03-044ATAI Life Sciences N.V. (ATAI)Grant/award (A): 228,000 (derivative) @ $0EDGAR
2021-07-074ATOSSA THERAPEUTICS, INC. (ATOS)Option exercise (M): 4,581 @ $5.64 · Option exercise (M): 45,000 @ $2.38 · Option exercise (M): 45,000 @ $2.52 · Option exercise (M): 70,000 @ $1.70 · Tax withholding (F): 57,084 @ $6.40 · Sale (S): 107,497 @ $5.58 · +4 moreEDGAR
2021-06-244ATAI Life Sciences N.V. (ATAI)Purchase (P): 4,666 @ $15EDGAR
2021-06-224ATAI Life Sciences N.V. (ATAI)Grant/award (A): 67,726 (derivative) @ $0EDGAR
2021-05-184ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1251779 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs